Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3767
UNCY
Unicycive Therapeutics, Inc. - Common Stock
5.27 USD-4.18%-6.56%+10.71%-19.05%146.80 M USD
3772
ADCT
ADC Therapeutics SA Common Shares
1.14 USD+1.79%+14.00%+0.88%-63.11%145.54 M USD
3786
CNTB
Connect Biopharma Holdings Limited - American Depositary Shares
2.23 USD-2.19%-5.51%+8.78%+8.78%140.43 M USD
3811
HURA
TuHURA Biosciences, Inc. - Common Stock
2.11 USD-0.94%+0.48%0.00%-21.56%134.46 M USD

Frequently asked questions about Milestone Pharmaceuticals Inc. Common Shares

What is the Milestone Pharmaceuticals Inc. Common Shares stock price today?

The current price of Milestone Pharmaceuticals Inc. Common Shares (MIST) is 1.16. Over the past 24 hours, the stock has changed by -2.52%. Follow the MIST chart for real-time price dynamics.

What is the stock ticker of Milestone Pharmaceuticals Inc. Common Shares?

Milestone Pharmaceuticals Inc. Common Shares trades under the ticker MIST. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Milestone Pharmaceuticals Inc. Common Shares stock going up?

MIST has changed by +9.43% over the last week, +11.54% over the last month, and -36.96% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Milestone Pharmaceuticals Inc. Common Shares?

Milestone Pharmaceuticals Inc. Common Shares currently has a market capitalization of 144.42 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Milestone Pharmaceuticals Inc. Common Shares earnings last quarter?

Last quarter, Milestone Pharmaceuticals Inc. Common Shares reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Milestone Pharmaceuticals Inc. Common Shares revenue for the last quarter?

Milestone Pharmaceuticals Inc. Common Shares reported quarterly revenue of 559 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Milestone Pharmaceuticals Inc. Common Shares net income for the last quarter?

Milestone Pharmaceuticals Inc. Common Shares reported net income of -28.61 M for the last quarter. The previous quarter showed -26.07 M, which means net income changed by -9.78%.

How many employees does Milestone Pharmaceuticals Inc. Common Shares have?

As of the latest available data, Milestone Pharmaceuticals Inc. Common Shares has 38 employees. Workforce size can provide additional context about the company's scale and operations.

What is Milestone Pharmaceuticals Inc. Common Shares EBITDA?

Milestone Pharmaceuticals Inc. Common Shares EBITDA is -25.57 M, and its EBITDA margin is -4 574.78%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Milestone Pharmaceuticals Inc. Common Shares stock?

You can buy Milestone Pharmaceuticals Inc. Common Shares (MIST) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Milestone Pharmaceuticals Inc. Common Shares stock?

Investing in Milestone Pharmaceuticals Inc. Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MIST chart and related analysis on metatrader.com as part of your research.

News